![SciELO - Brasil - Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in patients with gastric cancer Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in SciELO - Brasil - Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in patients with gastric cancer Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in](https://minio.scielo.br/documentstore/1678-9903/GbJpRsRZcNGws7b5bgPP8vc/ef6d70eda1098ff0140f9326c19031a935741531.gif)
SciELO - Brasil - Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in patients with gastric cancer Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in
![Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients | Anticancer Research Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/3/1691/F1.large.jpg)
Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients | Anticancer Research
![Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients | Anticancer Research Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/3/1691/F2.large.jpg)
Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients | Anticancer Research
![Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study](https://pub.mdpi-res.com/cancers/cancers-11-00733/article_deploy/html/images/cancers-11-00733-g001.png?1571594573)
Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study
![The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0304419X21001323-gr2.jpg)
The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect
![Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer | Semantic Scholar Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/895971fec3a1231c762fbc95d48807da16a4ad85/3-TableII-1.png)
Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer | Semantic Scholar
![Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cancer | Future Science OA Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cancer | Future Science OA](https://www.future-science.com/cms/10.4155/fsoa-2016-0040/asset/images/medium/figure1.gif)
Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cancer | Future Science OA
CA 72.4 ( TAG-72); GASTRIC CANCER MARKER, SERUM (ECLIA) U/mL < 6.00 Note: 1.This test is not recommended to screen Gastric c
![CA 72-4 marker: adjunct to conventional biomarkers in monitoring of pancreatic, ovarian and colorectal cancers. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc. CA 72-4 marker: adjunct to conventional biomarkers in monitoring of pancreatic, ovarian and colorectal cancers. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc.](https://www.advimmuno.com/wp-content/uploads/2019/04/CA72-4.jpeg)
CA 72-4 marker: adjunct to conventional biomarkers in monitoring of pancreatic, ovarian and colorectal cancers. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc.
![Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study](https://pub.mdpi-res.com/cancers/cancers-11-00733/article_deploy/html/images/cancers-11-00733-g001-550.jpg?1571594573)
Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study
![Clinical risk factors of gastric cancer (GC) and tumor markers in high... | Download Scientific Diagram Clinical risk factors of gastric cancer (GC) and tumor markers in high... | Download Scientific Diagram](https://www.researchgate.net/publication/333406730/figure/tbl1/AS:763345779052544@1559007224001/Clinical-risk-factors-of-gastric-cancer-GC-and-tumor-markers-in-high-and-normal-CA72-4.png)
Clinical risk factors of gastric cancer (GC) and tumor markers in high... | Download Scientific Diagram
![Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries | Anticancer Research Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/37/7/3649/F1.large.jpg)
Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries | Anticancer Research
![SciELO - Brasil - CA72-4 antigen levels in serum and peritoneal washing in gastric cancer: correlation with morphological aspects of neoplasia CA72-4 antigen levels in serum and peritoneal washing in gastric cancer: SciELO - Brasil - CA72-4 antigen levels in serum and peritoneal washing in gastric cancer: correlation with morphological aspects of neoplasia CA72-4 antigen levels in serum and peritoneal washing in gastric cancer:](https://minio.scielo.br/documentstore/1678-4219/JNM5z8CYtgQ3DMmZjBLL5Rb/6ccf329c1af84c39406bf5701e2e30ca1936b7bc.gif)
SciELO - Brasil - CA72-4 antigen levels in serum and peritoneal washing in gastric cancer: correlation with morphological aspects of neoplasia CA72-4 antigen levels in serum and peritoneal washing in gastric cancer:
![Measuring Intragastric Tumor Markers in Gastric Cancer Patients: a Systematic Literature Review on Significance and Reliability | Anticancer Research Measuring Intragastric Tumor Markers in Gastric Cancer Patients: a Systematic Literature Review on Significance and Reliability | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/37/6/2817/T1.medium.gif)
Measuring Intragastric Tumor Markers in Gastric Cancer Patients: a Systematic Literature Review on Significance and Reliability | Anticancer Research
![Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer | Semantic Scholar Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/895971fec3a1231c762fbc95d48807da16a4ad85/5-TableVI-1.png)
Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer | Semantic Scholar
![Premium Photo | Technician hold blood sample for ca 72 4 test tumor marker for gastrointestinal cancer Premium Photo | Technician hold blood sample for ca 72 4 test tumor marker for gastrointestinal cancer](https://img.freepik.com/premium-photo/technician-hold-blood-sample-ca-72-4-test-tumor-marker-gastrointestinal-cancer_595440-733.jpg)
Premium Photo | Technician hold blood sample for ca 72 4 test tumor marker for gastrointestinal cancer
![CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy | BMC Cancer | Full Text CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07666-8/MediaObjects/12885_2020_7666_Fig3_HTML.png)